Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRS Group Regulatory News (RS1)

Share Price Information for RS Group (RS1)

Share Price is delayed by 15 minutes
Get Live Data
619.50    -0.50 (-0.08%)
Bid:
619.00
Ask:
620.00
Spread: 1.00 (0.162%)
Market Cap: £2.86b
RS1 Live PriceLast checked at - London Stock Exchange

Intraday RS Group Share Chart

Pre-Close Trading Update

25 Mar 2026 07:00

RNS Number : 9752X
RS Group PLC
25 March 2026
 

 

 

25 March 2026, 7.00am

 

RS GROUP PLC

 

Pre-close trading update

 

Full year 2025/26 adjusted profit before tax marginally ahead of expectations

RS Group plc (the "Group") today announces that for the 12 months ended 31 March 2026, in difficult markets, revenue is now expected to decline by approximately 0.6%1 on a like-for-like2 basis. EMEA has delivered quarter on quarter improvement throughout the year and we anticipate that it will return to marginal growth in H2 2026. APAC is showing continued momentum, and we expect it to deliver increased revenue growth in H2 2026 when compared to H1 2026. Although Americas was broadly flat in H1 2026, we expect it to decline in H2 2026 as a result of the continuing challenging trading environment in Mexico.

 

We continue to invest and make good progress in our strategic and change initiatives. As a result, despite revenue being lower than anticipated, through a solid gross margin performance, improved efficiency and disciplined cost control, we still expect adjusted profit before tax to be marginally ahead of market expectations1,3.

 

Notice of results

RS Group plc expects to announce its full year 2025/26 results on Thursday 20 May 2026.

 

Notes:

1. These results are unaudited, and audited full year results will be reported on 20 May 2026

2. Like-for-like revenue and profit measures are adjusted to exclude the effects of changes in exchange rates on translation of overseas profits. They exclude acquisitions in the relevant years until they have been owned for a year, at which point they start to be included in both the current and comparative years for the same number of months. These measures enable management and investors to track more easily, and consistently, the performance of the business.

3. Company compiled consensus for the year ended 31 March 2026 for adjusted profit before tax of £241 million, within a range of £230 million to £247 million (source: RSGroup.com/investors/analyst-consensus).

 

 

Enquiries:

Kate Ringrose

Chief Financial Officer

020 7239 8400

Carla Bloom

VP Investor Relations

020 7239 8427

Martin Robinson

Teneo Communications

020 7260 2700

 

 

 

About RS Group 

RS is a high-service global product and service solutions provider for industrial customers, enabling them to operate efficiently and sustainably. We operate in 36 markets, stock over 830,000 industrial and specialist products and list an additional five million relevant for our industrial customers, sourced from over 2,500 suppliers. This extensive range supports our customers across the industrial lifecycle of designing, building and maintaining equipment and operations. We enhance their experience through a tailored service model, leveraging our efficient physical, digital and process infrastructure sustainably. We combine a technically led and digitally enabled approach with an exceptional team of experts; ultimately, it's our people that make the difference. Our purpose, making amazing happen for a better world, reflects our focus on delivering results for people, planet and profit. RS Group plc is listed on the London Stock Exchange with stock ticker RS1 and in the year ended 31 March 2025 reported revenue of £2,904 million.

 

For more information, please visit www.rsgroup.com  

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBIGDXRXDDGLS
Date   Source Headline
2nd Sep 202411:00 amRNSTotal Voting Rights
6th Aug 202410:00 amRNSDirector/PDMR Shareholding
1st Aug 20244:06 pmRNSTotal Voting Rights
1st Aug 20242:00 pmRNSBlock listing Interim Review
24th Jul 202411:00 amRNSDirector/PDMR Shareholding
17th Jul 202411:30 amRNSDirectorate Change
11th Jul 20243:14 pmRNSResult of AGM
11th Jul 20247:00 amRNSAGM Update
2nd Jul 20242:00 pmRNSDirector/PDMR Shareholding
2nd Jul 20242:00 pmRNSDirector/PDMR Shareholding
7th Jun 202410:00 amRNSDirector/PDMR Shareholding
6th Jun 202412:00 pmRNSAnnual Financial Report
3rd Jun 20241:03 pmRNSTotal Voting Rights
30th May 20245:26 pmRNSDirector/PDMR Shareholding
23rd May 202410:00 amRNSDirector/PDMR Shareholding
22nd May 20247:00 amRNSFinal Results
10th May 20245:28 pmRNSHolding(s) in Company
1st May 20249:40 amRNSTotal Voting Rights
26th Apr 20243:00 pmRNSDirector Declaration
2nd Apr 202410:00 amRNSTotal Voting Rights
19th Mar 202410:00 amRNSBlock Listing Application
1st Mar 20249:27 amRNSTotal Voting Rights
1st Feb 20241:18 pmRNSBlock listing Interim Review
1st Feb 202410:21 amRNSTotal Voting Rights
25th Jan 20247:00 amRNSTrading Statement
10th Jan 202411:00 amRNSDirector/PDMR Shareholding
2nd Jan 202410:56 amRNSTotal Voting Rights
18th Dec 20234:00 pmRNSDirector Declaration
8th Dec 20239:00 amRNSDirector/PDMR Shareholding
1st Dec 20239:21 amRNSTotal Voting Rights
17th Nov 20232:24 pmRNSHolding(s) in Company
16th Nov 20238:00 amRNSDirector/PDMR Shareholding
14th Nov 20234:00 pmRNSDirector/PDMR Shareholding
8th Nov 20238:00 amRNSDirector/PDMR Shareholding
7th Nov 20237:00 amRNSHalf-year Report
1st Nov 202312:24 pmRNSTotal Voting Rights
2nd Oct 20239:50 amRNSTotal Voting Rights
1st Sep 20239:41 amRNSTotal Voting Rights
21st Aug 20238:00 amRNSDirector/PDMR Shareholding
1st Aug 20232:44 pmRNSBlock listing Interim Review
28th Jul 20239:00 amRNSDirector/PDMR Shareholding
27th Jul 20239:00 amRNSHolding(s) in Company
27th Jul 20237:00 amRNSAppointment of Kate Ringrose as CFO
27th Jul 20237:00 amRNSQ1 Trading Update
26th Jul 20234:53 pmRNSDirector/PDMR Shareholding
25th Jul 20239:24 amRNSHolding(s) in Company
25th Jul 20238:15 amRNSHolding(s) in Company
14th Jul 202311:56 amRNSHolding(s) in Company
13th Jul 20232:35 pmRNSResult of AGM
3rd Jul 202310:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.